Bizzarri Nicolò, Rosati Andrea, Scambia Giovanni, Fanfani Francesco
Fondazione Policlinico Universitario A. Gemelli, IRCCS, UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Rome, Italy.
Università Cattolica del Sacro Cuore, Istituto di Ginecologia e Ostetricia, Rome, Italy.
Ann Surg Oncol. 2022 Jan;29(1):683. doi: 10.1245/s10434-021-10559-0. Epub 2021 Aug 13.
Occult endometrial cancer after supracervical hysterectomy is uncommon. Even if optimal management of those rare cases is still unproven, to guide the need for adjuvant treatment, restaging should be recommended in this situation.
The study was approved by institutional review board (DIPUSVSP-27-07-20107). We report the case of a 52-year-old woman with occult grade 2 endometrioid endometrial adenocarcinoma (pT1a) with negative surgical margin and smooth uterine muscle of uncertain malignant potential after supracervical hysterectomy and bilateral salpingo-oophorectomy performed for pelvic pain and uterine fibroids in a local hospital. Preoperative CT scan of chest-abdomen-pelvis did not show any lymphadenopathy or distant metastasis. Pelvic US scan revealed a normal cervical stump and a hypoechoic 18-mm right parametrial nodule. We describe the feasibility of laparoscopic sentinel lymph node identification with cervical stump injection of indocyanine green.
The patient underwent laparoscopic radical trachelectomy, left pelvic sentinel lymph node biopsy, right pelvic lymphadenectomy, peritoneal washing. Patient did not report any intraoperative or postoperative complication. At final histology cervix, SLN (ultrastaging) and pelvic lymph nodes were negative, while parametrial nodule was reported as metastasis from endometrial adenocarcinoma. Surgical margins were clear. Patient was staged as FIGO IIIB and underwent adjuvant chemo-radiation. She is now alive and disease-free, 12 months after the surgery.
This video (Video 1) underlines the fact that SLN mapping with cervical injection is a feasible and safe technique also without the uterine corpus after supracervical hysterectomy. The unilateral mapping could be due to the presence of metastatic parametrium on the right side.
次全子宫切除术后隐匿性子宫内膜癌并不常见。即便这些罕见病例的最佳治疗方案仍未得到证实,但为了指导辅助治疗的必要性,在这种情况下应建议进行再次分期。
本研究经机构审查委员会批准(DIPUSVSP - 27 - 07 - 20107)。我们报告一例52岁女性患者,因盆腔疼痛和子宫肌瘤在当地医院行次全子宫切除术及双侧输卵管卵巢切除术,术后病理为隐匿性2级子宫内膜样腺癌(pT1a),手术切缘阴性,子宫平滑肌恶性潜能不确定。术前胸腹部盆腔CT扫描未显示任何淋巴结肿大或远处转移。盆腔超声扫描显示宫颈残端正常,右侧宫旁有一个18mm的低回声结节。我们描述了通过向宫颈残端注射吲哚菁绿进行腹腔镜前哨淋巴结识别的可行性。
患者接受了腹腔镜根治性宫颈切除术、左侧盆腔前哨淋巴结活检、右侧盆腔淋巴结清扫及腹腔冲洗。患者未报告任何术中或术后并发症。最终组织学检查显示宫颈、前哨淋巴结(超分期)及盆腔淋巴结均为阴性,而宫旁结节被报告为子宫内膜腺癌转移。手术切缘清晰。患者分期为FIGO IIIB期,接受了辅助放化疗。术后12个月,她目前存活且无疾病复发。
本视频(视频1)强调了这样一个事实,即对于次全子宫切除术后无子宫体的患者,经宫颈注射进行前哨淋巴结定位是一种可行且安全的技术。单侧定位可能是由于右侧存在转移性宫旁组织。